Recombinant Human PVR protein, C-hFc-Avi Tag, Biotinylated
Product Description
Cat
IMP-079
Official Symbol
PVR
Product Overview
Biotinylated Recombinant Human PVR protein(AA Trp 21-Asn 343)(Accession # NP_006496.2) is expressed from human 293 cells (HEK293). This protein carries a human IgG1 Fc tag at the C-terminus, followed by a Avi tag.
Expression System
HEK293
Species
Human
Tag
C-hFc-Avi Tag
Form
Lyophilized from sterile Tris with Glycine, Arginine and NaCl, pH7.5, 10% trehalose.
Conjugate
Biotinylated
Molecular Mass
The protein has a calculated MW of 63.5 kDa. As a result of glycosylation, the protein migrates as 75-100 kDa under reducing (R) condition, and 140-180 kDa under non-reducing (NR) condition (SDS-PAGE).
Protein length
Trp 21-Asn 343
Endotoxin
Less than 1.0 EU per ug by the LAL method.
Purity
>95% as determined by SDS-PAGE.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower. Please avoid repeated freeze-thaw cycles. This product is stable after storage at: -20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution.
Reconstitution
It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 mg/ml. Centrifuge the vial at 4ºC before opening to recover the entire contents.
Bioactivity-FACS Title 2
Bioactivity-FACS
SDS-PAGE
SDS-PAGE

Biotinylated Human CD155, Fc,Avitag on SDS-PAGE under reducing (R) and non-reducing (NR) conditions. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

Bioactivity-ELISA 1
Bioactivity-ELISA

Immobilized Human TIGIT, Fc Tag at 2 ug/mL (100 uL/well) can bind Biotinylated Human CD155, Fc,Avitag with a linear range of 0.5-16 ng/mL.

Bioactivity-ELISA 2
Bioactivity-ELISA

Immobilized Human DNAM-1, Fc Tag at 2 ug/mL (100 uL/well) can bind Biotinylated Human CD155, Fc,Avitag with a linear range of 0.02-0.312 ug/mL.

Bioactivity-ELISA 3
Bioactivity-ELISA

Serial dilutions of TIGIT antibody antibody (1:2 serial dilutions, from 20 ug/mL to 0.0097 ug/mL) were added into Human TIGIT, His Tag: Biotinylated Human CD155, Fc,Avitag binding reactions. The assay was performed according to the above described protocol. Background was subtracted from data points before curve fitting.

Bioactivity-FACS 1
Bioactivity-FACS

FACS assay shows that Biotinylated Human CD155, Fc,Avitag can bind to 293T cell overexpressing human TIGIT. The concentration of CD155 is 1 ug/mL.

Bioactivity-FACS 2
FACS analysis shows that the binding of Biotinylated Human CD155, Fc,Avitag to 293T overexpressing TIGIT was inhibited by increasing concentration of neutralizing Anti-Human TIGIT MAb. The concentration of CD155 used is 1 ug/mL. The IC50 is 0.201 ug/mL.

FACS analysis shows that the binding of Biotinylated Human CD155, Fc,Avitag to 293T overexpressing TIGIT was inhibited by increasing concentration of neutralizing Anti-Human TIGIT MAb. The concentration of CD155 used is 1 ug/mL. The IC50 is 0.201 ug/mL.

Data Sheet MSDS
For research or industrial raw materials, not for personal medical use!

Online Inquiry
Contact Info